Submit your research today!
Your valuable research in Expert Opinion on Biological Therapy - Bispecific Antibodies
About the special issue
Enthusiasm for developing bispecific antibodies (BsAbs) is increasing, and, with their ability to bind two different epitopes on the same or different antigens, BsAbs provide a tremendous opportunity for therapeutic application. Progress in developing therapeutic BsAbs has been facilitated by advances in molecular biology, hybridoma technology, and protein engineering. With these platforms, it is hoped that BsAb development will lead to improved clinical outcomes, particularly in oncology where many are showing promise in clinical trials.
To show our commitment to this important field of research, Expert Opinion on Biological Therapy will be publishing a best-in-class special issue on BsAbs in the summer of 2022. With contributions from world-class key opinion leaders from across academia and industry, the issue will cover potential therapeutic targets, agents in pre-clinical development, agents in clinical trials, combinatorial therapies, and future directions. What’s more, the issue will provide an ideal blend of original research, reviews and editorial articles: a one-stop-shop for all things bSAbs.
By publishing in Expert Opinion on Biological Therapy you will:
- Gain recognition from an international audience and increase your opportunities for future collaboration
- Receive 50 free e-prints & promotional tips on promoting your article courtesy of our Author Services site
- Immediately see the impact of your research made in the community by tracking downloads, citations, and the Altmetric Score of your article on My Authored Works
- Increase the discoverability of your research with MEDLINE listings and more